Kenneth Leinart

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when Pharming Group N.V. publishes a filing, an earnings call transcript or a press release.

Get PHAR alerts

About Kenneth Leinart

Kenneth Leinart is recorded as CFO at Pharming Group N.V. (PHAR). Kenneth Leinart has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Pharming Group N.V. on October 27, 2026. Pharming Group N.V. is classified in the Biotechnology industry within the Healthcare sector.

Kenneth Leinart on recent calls

“Good morning and good afternoon, everyone, and thank you for joining Farming's third quarter 2026 call. I'm joined today by Laverne Marsh, my fellow interim co-CEO and our chief commercial officer, and Dr. Anurag Raylan, our chief medical officer.”

CEO, Pharming 3Q 2026 Financial Results · October 27, 2026

“Unfortunately, due to personal reasons, our CEO, Fabrice Shoaki, is not able to attend today and Michael and myself will share the presentation and the updates that we have prepared for you.”

CFO, H.C. Wainwright 28th Annual Global Investment Conference · September 14, 2026

“I'm pleased to now provide some color on our strong 2025 financial performance and our outlook for 2026. The fourth quarter was a strong finish with revenues of $106.5 million, being 15% growth versus Q4 of 2024.”

CFO, Q4 Earnings conference call (announced in 6-K) · March 12, 2026